Clinical Trial Update: The Improvement of Low-dose Esketamine on Postoperative Depression in Patients Undergoing Bariatric Surgery With Preoperative Depression [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing whether low-dose esketamine can improve postoperative depression in patients undergoing bariatric surgery with preoperative d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Obesity

Drugs mentioned

• Esketamine (esketamine)

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: Depressed, Bariatric Surgery | Phase 4 | Status: NOT_YET_RECRUITING